| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 03/30/1999 | US5888992 Polar substituted hydrocarbons |
| 03/30/1999 | US5888741 Computer-based design and screening of molecules using DNA interactions |
| 03/30/1999 | US5888738 Design of drugs involving receptor-ligand-DNA interactions |
| 03/25/1999 | WO1999014207A1 Substituted indan derivatives |
| 03/25/1999 | WO1999014199A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments |
| 03/25/1999 | WO1999014193A1 Insecticidal oximino and hydrazono derivatives of n-benzyl-4-benzhydryl- and n-benzyl-4benzhydrolpiperidines |
| 03/25/1999 | WO1999014185A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments |
| 03/25/1999 | WO1999014175A1 Perfluoroalkyl haloalkyl ethers and compositions and applications thereof |
| 03/25/1999 | WO1999001427A3 Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 03/25/1999 | DE19742014A1 Use of new and known tetracyclene compounds as phospholipase inhibitors |
| 03/25/1999 | DE19741400A1 New benzyl-biphenyl derivatives |
| 03/25/1999 | CA2303839A1 Substituted indan derivatives |
| 03/25/1999 | CA2303323A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments |
| 03/24/1999 | EP0903349A2 CCR-3 receptor antagonists |
| 03/24/1999 | EP0784619B1 Phenyl-oxo-alkyl-(4-piperidinyl)benzoate derivatives |
| 03/24/1999 | EP0664786B1 Arginine keto-amide enzyme inhibitors |
| 03/24/1999 | CN1212019A Method and compositions for detecting binding of ligand pair using non-fluorescent label |
| 03/24/1999 | CN1211572A Cyclic amine derivatives-CCR-3 receptor antagonists |
| 03/23/1999 | US5885999 Treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
| 03/23/1999 | US5885967 Anticoagulants |
| 03/23/1999 | CA2096293C Alkene carboxylic acid derivatives, method of preparation thereof and pharmaceutical compositions containing them |
| 03/18/1999 | WO1999012931A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 03/18/1999 | WO1999012924A1 Piperidinylmethyloxazolidinone derivative |
| 03/18/1999 | WO1999012893A1 Diagnostic and therapeutic alkylenediamine compounds and process |
| 03/18/1999 | DE19740110A1 New hydroxy substituted benzomorphan derivatives |
| 03/18/1999 | CA2303249A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 03/17/1999 | EP0902017A1 Transesterification process |
| 03/17/1999 | EP0902016A1 A process and intermediate compounds for the preparation of amlodipine benzene sulphonate |
| 03/17/1999 | EP0901468A1 PREPARATION OF LACTAMS FROM ALIPHATIC $g(a),$g(v)-DINITRILES |
| 03/17/1999 | CN1211251A 1,4-dihydropyridine compounds as bradykinin antagonists |
| 03/17/1999 | CN1211247A Novel substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases |
| 03/16/1999 | US5883257 N-piperidinyl- and N-tetrahydropyridinyl-2-anthracenecarboxamides: dopamine receptor subtype specific ligands |
| 03/16/1999 | US5883251 Enzyme inhibitors |
| 03/16/1999 | US5883099 Treatment of athersclerosis, pancreatitis obesity or hyperglycemia |
| 03/16/1999 | US5883096 Di-n-substituted piperazine derivatives; alzheimer*s disease, cognition activators; synergistic mixtures with acetylcholinesterase inhibitors |
| 03/16/1999 | CA2164689C Nk-1 receptor antagonists and 5ht3 receptor antagonists for the treatment of emesis |
| 03/16/1999 | CA2158108C Compositions containing sertraline and a 5-ht1d receptor agonist or antagonist |
| 03/16/1999 | CA1340443C Imidoperoxycarboxylic acids, processes for their preparation and their use |
| 03/11/1999 | WO1999011617A1 Novel naphthamide derivatives or salts thereof |
| 03/11/1999 | WO1999011258A1 Lymphocyte function antigen-1 antagonists |
| 03/10/1999 | EP0900782A1 2-Cyanoacrylic acid esters |
| 03/10/1999 | EP0900224A1 Propagylglycine derivatives, preparation and utilisation thereof as synthesis intermediates |
| 03/10/1999 | EP0733049B1 Tricyclic derivatives and their use in pharmaceuticals |
| 03/10/1999 | CN1210104A Reducted haloperidol quarternary ammonium salt deravitives and synthesis thereof |
| 03/09/1999 | US5880295 Process for the preparation of diamine intermediates useful in the synthesis of HIV protease inhibitors |
| 03/09/1999 | US5880286 Acetylation of sterically hindered diamines |
| 03/09/1999 | US5880230 Adding compounds containing or capable of forming a stable nitroxyl free radical, such as 4-hydroxy-2,2,6,6-tetramethyl piperidine-1-oxyl; synthetic rubber production; no nitrosamine precursors |
| 03/09/1999 | US5880147 Amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prohylactic use |
| 03/09/1999 | US5880136 Sulfonamide fibrinogen receptor antagonists |
| 03/09/1999 | US5880128 Inhibit abnormal growth of cells |
| 03/09/1999 | US5879681 Compounds and compositions for delivering active agents |
| 03/04/1999 | WO1999010340A1 Compounds possessing neuronal activity |
| 03/04/1999 | WO1999010338A2 Benzylidene- and cinnamylidene-anabaseines as neuronal nicotinic alpha-7 receptor agonists |
| 03/04/1999 | WO1999010316A1 3-amidinoaniline derivatives, activated blood coagulation factor x inhibitors, and intermediates for producing both |
| 03/04/1999 | WO1999010313A1 N-aroylphenylalanine derivatives |
| 03/04/1999 | WO1999010312A1 N-alkanoylphenylalanine derivatives |
| 03/04/1999 | WO1999009987A1 Method for treating premenstrual or late luteal phase syndrome |
| 03/04/1999 | WO1999009984A1 Pyrrolidine and piperidine modulators of chemokine receptor activity |
| 03/04/1999 | CA2301559A1 3-amidinoaniline derivatives, activated blood coagulation factor x inhibitors, and intermediates for producing both |
| 03/04/1999 | CA2300134A1 Compounds possessing neuronal activity |
| 03/04/1999 | CA2300121A1 N-alkanoylphenylalanine derivatives |
| 03/04/1999 | CA2298979A1 Method for treating premenstrual or late luteal phase syndrome |
| 03/04/1999 | CA2298813A1 Pyrrolidine and piperidine modulators of chemokine receptor activity |
| 03/03/1999 | EP0899261A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists |
| 03/03/1999 | EP0899260A1 Stabilizers for organic materials |
| 03/03/1999 | EP0898569A1 Piperidines and pyrrolidines |
| 03/03/1999 | EP0724570B1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 03/03/1999 | CN1209803A Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method therefor |
| 03/03/1999 | CN1042335C 1-acylpiperidine compounds, preparation method, medicinal composition and use thereof |
| 03/02/1999 | US5877344 Synergistic mixture |
| 03/02/1999 | US5877321 Neurokinin receptor |
| 03/02/1999 | US5877200 Cyclic amides |
| 03/02/1999 | US5877189 Pure isomer |
| 03/02/1999 | US5877188 Psychological and behavioral disorders, antiemetics |
| 03/02/1999 | US5876710 Drug delivery; using a brominated benzamide compound |
| 03/02/1999 | US5876694 Azavesamicols |
| 02/25/1999 | DE19837386A1 New CCR-3 antagonist piperazine derivatives and analogues |
| 02/24/1999 | EP0897913A1 4-carboxamido piperidine derivatives and their use as neurokinine antagonists |
| 02/24/1999 | EP0897912A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 02/24/1999 | CN1209124A Novel compounds with analgesic effect |
| 02/23/1999 | US5874589 Methods for synthesizing diverse collections of tetramic acids and derivatives thereof |
| 02/23/1999 | US5874467 Phenylacetic acid derivatives and use as fungicides |
| 02/23/1999 | US5874449 Inhibitors of immunophilin |
| 02/23/1999 | US5874447 High purity organosulfonate salt of paroxetine with excellent stability, solubility; react with a base to make high purity paroxetine, or with a reagent to make the high purity salt of said reagent (ex: paroxetine maleate from maleic acid) |
| 02/23/1999 | US5874445 (+) -α- (2,3-dimethoxyphenyl)-1-(2-(4-fluorephenyl) ethyl)-4-piepridinemethanol |
| 02/23/1999 | US5874433 Treating prophylaxis or hypotension induced by cytokine therapy or exposure to bacterial endotoxin by administering a nitric oxide synthase inhibitor |
| 02/23/1999 | US5874428 N-substituted aza-heterocyclic carboxylic acids and esters thereof |
| 02/18/1999 | WO1999008299A1 Nonaqueous electrolyte for electrical storage devices |
| 02/18/1999 | WO1999007689A1 Aniline derivatives as calcium channel blockers |
| 02/18/1999 | WO1999007680A1 Stereoselective preparation of 3-substituted 4-aryl piperidine compounds |
| 02/18/1999 | WO1999007675A1 Aryloxyarylsulfonylamino hydroxamic acid derivatives |
| 02/18/1999 | WO1999007672A1 Derivatives of 2,5- and 3,5-disubstituted anilines, their preparation and use |
| 02/18/1999 | WO1999007377A1 1-[4-(substituted alkoxy)benzyl]naphthalene compounds having estrogen inhibitory activity |
| 02/18/1999 | WO1998046342A3 Preparation of low-dust stabilisers |
| 02/18/1999 | CA2298651A1 1-¬4-(substituted alkoxy)benzyl|naphthalene compounds having estrogen inhibitory activity |
| 02/18/1999 | CA2245043A1 Ccr-3 receptor antagonists |
| 02/18/1999 | CA2245041A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists |
| 02/17/1999 | EP0896980A1 Novel light stabilisers based on calix[n]arenes and resorc[n]arenes |
| 02/17/1999 | EP0896590A1 Rapid purification by polymer supported quench |
| 02/17/1999 | EP0896539A1 Methods for treating emesis and central nervous system disorders using optically pure (+) norcisapride |